| |
Environment as important as genes in autism, study finds Saturday, May 03, 2014 01:41 PM PDT By Kate Kelland LONDON (Reuters) - Environmental factors are more important than previously thought in leading to autism, as big a factor as genes, according to the largest analysis to date to look at how the brain disorder runs in families. Sven Sandin, who worked on the study at King's College London and Sweden's Karolinska institute, said it was prompted "by a very basic question which parents often ask: 'If I have a child with autism, what is the risk my next child will too?'" The findings, published in the Journal of the American Medical Association (JAMA), suggest heritability is only half the story, with the other 50 percent explained by environmental factors such as birth complications, socio-economic status, or parental health and lifestyle. The study also found that children with a brother or sister with autism are 10 times more likely to develop the condition, three times if they have a half-brother or sister with autism, and twice as likely if they have a cousin with autism. Full Story | Top |
Boy who survived flight in wheel well 'no longer in Hawaii' Saturday, May 03, 2014 01:30 PM PDT | Top |
Indiana hospital caring for MERS patient still bustling Saturday, May 03, 2014 11:54 AM PDT | Top |
Saudi Arabia reports 25 new cases of MERS, deaths stand at 109 Saturday, May 03, 2014 06:26 AM PDT | Top |
Pfizer expected to be patient in face of AstraZeneca rejection Saturday, May 03, 2014 05:11 AM PDT Pfizer Inc has already had its takeover overtures rebuffed three times by rival AstraZeneca Plc, but investors in the U.S. drugmaker say it can tolerate a little more rejection before going hostile with the deal. AstraZeneca turned down a sweetened Pfizer cash and stock offer on Friday that amounted to 63 billion pounds ($106 billion), or about 50 pounds per share, saying it substantially undervalued the British drugmaker. The raised offer followed unsolicited Pfizer approaches in late April and January. Investors and analysts say Pfizer needs to raise its offer as high as 52 to 55 pounds per share to close the deal, as well as increase the cash portion to as much as 50 percent from around 30 percent. Full Story | Top |
Pfizer U.S. research jobs jeopardized by promises to UK for merger Saturday, May 03, 2014 05:09 AM PDT | Top |
Marijuana banking scheme passes first test in Colorado legislature Friday, May 02, 2014 10:11 PM PDT By Keith Coffman DENVER (Reuters) - Colorado lawmakers on Friday passed a bill that if enacted would lead to the first marijuana financial system in the United States, potentially granting legal cannabis businesses access to the Federal Reserve's money transaction system. Traditional banks have been wary to knowingly serve legal and medicinal marijuana businesses because the drug remains illegal under federal law, said the bill's sponsor, Representative Jonathan Singer. "This sets up a new type of financial structure to the gap we're seeing between banking and the marijuana industry," said Singer, a Democrat. The proposal calls for new "cannabis credit co-ops" - similar to credit unions without deposit insurance - to be governed by the state's financial services commissioner. Full Story | Top |
|
No comments:
Post a Comment